Molecular Diagnostics Market Overview Size, Share & Key Players
FAQ's
Answer : According to Precedence Research, the global implantable medical devices market size was reached at US$ 86.3 billion in 2020 and is expected to be worth around US$ 145.6 billion by 2030.
Answer : The implantable medical devices market is growing at a CAGR of 7% from 2021 to 2030.
Answer : The global implantable medical devices market is driven by the rising demand for replacement or support of the bones, joints or other body tissues, owing to the rising prevalence of chronic diseases, rising cases of accidents, and trauma.
Answer : Based on region, North America dominated the global implantable medical devices market in 2020, in terms of revenue and is estimated to sustain its dominance during the forecast period.
Answer : Some of the prominent players operating in the global implantable medical devices market are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., CONMED Corporation, Globus Medical, Inc., Johnson & Johnson, LivaNova PLC, Medtronic plc, NuVasive, Inc., Smith & Nephew plc, St. Jude Medical, Inc., InstitutStraumann AG.
Get a Sample of this Report
Molecular Diagnostics Market
